{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:13:15Z","timestamp":1778883195248,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020180","name":"Japanese Society of Allergology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jaci.2025.06.025","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T21:15:18Z","timestamp":1751663718000},"page":"1401-1409.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of potential transcriptomic and microRNA markers to assess benralizumab effectiveness"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-3508","authenticated-orcid":false,"given":"Keita","family":"Hirai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sekiko","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.06.025_bib1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.06.025_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaip.2023.01.011","article-title":"Treatable traits in airway disease: from theory to practice","volume":"11","author":"Agusti","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.06.025_bib3","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.06.025_bib4","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.06.025_bib5","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.06.025_bib6","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1111\/all.16346","article-title":"Targeting the IL-5 pathway in eosinophilic asthma: a comparison of anti-IL-5 versus anti-IL-5 receptor agents","volume":"79","author":"Jackson","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.06.025_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.06.025_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01521-2023","article-title":"Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme","volume":"64","author":"Jackson","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.06.025_bib9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1164\/rccm.201604-0866OC","article-title":"A severe asthma disease signature from gene expression profiling of peripheral blood from U-BIOPRED cohorts","volume":"195","author":"Bigler","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.06.025_bib10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2024.01.014","article-title":"Analytical challenges in omics research on asthma and allergy: a National Institute of Allergy and Infectious Diseases workshop","volume":"153","author":"Bunyavanich","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.06.025_bib11","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/all.14646","article-title":"Spotlight on microRNAs in allergy and asthma","volume":"76","author":"Weidner","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.06.025_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411499","article-title":"miRNAs as modern biomarkers in asthma therapy","volume":"24","author":"Kierbied\u017a-Guzik","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.06.025_bib13","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/all.14819","article-title":"Benralizumab restores gene and microRNA expression involved in steroid sensitivity in severe asthma","volume":"76","author":"Hirai","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.06.025_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2350-11-138","article-title":"Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population","volume":"11","author":"Lee","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jaci.2025.06.025_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12931-018-0968-8","article-title":"Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases","volume":"20","author":"Sridhar","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2025.06.025_bib16","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1111\/all.15869","article-title":"Transcriptomics reveals new regulatory mechanisms involved in benralizumab response","volume":"78","author":"Estrav\u00eds","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.06.025_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaci.2020.08.004","article-title":"Identification of whole blood gene expressions correlated with responsiveness to benralizumab","volume":"147","author":"Nakajima","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.06.025_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/jpm11020076","article-title":"Serum microRNAs as tool to predict early response to benralizumab in severe eosinophilic asthma","volume":"11","author":"Ca\u00f1as","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaci.2025.06.025_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11033-024-10107-5","article-title":"The role of mir-7-5p in cancer: function, prognosis, diagnosis, and therapeutic implications","volume":"52","author":"Mirzaei","year":"2024","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jaci.2025.06.025_bib20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/biom13081185","article-title":"MicroRNA-7: a new intervention target for inflammation and related diseases","volume":"13","author":"Chen","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaci.2025.06.025_bib21","article-title":"Long noncoding RNA antisense noncoding RNA in the INK4 locus inhibition alleviates airway remodeling in asthma through the regulation of the microRNA-7-5p\/early growth response factor 3 axis","volume":"11","author":"Wang","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaci.2025.06.025_bib22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.immuni.2015.04.012","article-title":"Integrin \u03b1v\u03b28-mediated TGF-\u03b2 activation by effector regulatory T cells is essential for suppression of T-cell-mediated inflammation","volume":"42","author":"Worthington","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.06.025_bib23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2021.04.019","article-title":"Eight novel susceptibility loci and putative causal variants in atopic dermatitis","volume":"148","author":"Tanaka","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.06.025_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1164\/rccm.201908-1610LE","article-title":"A novel role for bronchial microRNAs and long noncoding RNAs in asthma remission","volume":"202","author":"Boudewijn","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.06.025_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/all.13570","article-title":"Asthma diagnosis using integrated analysis of eosinophil microRNAs","volume":"74","author":"Rodrigo-Mu\u00f1oz","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.06.025_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.06.025_bib27","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/all.14819","article-title":"Benralizumab restores gene and microRNA expression involved in steroid sensitivity in severe asthma","volume":"76","author":"Hirai","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.06.025_bib28","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2025.06.025_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2025.06.025_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2025.06.025_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2105-14-219","article-title":"TCC: an R package for comparing tag count data with robust normalization strategies","volume":"14","author":"Sun","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2025.06.025_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2025.06.025_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaci.2025.06.025_bib34","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat Protoc"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925007353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925007353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:30:15Z","timestamp":1778880615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925007353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0091674925007353"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.06.025","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of potential transcriptomic and microRNA markers to assess benralizumab effectiveness","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}